0001736297-26-000020
SEC filingRevenue surged 93% YoY to $308.4M, driven by Scorpio, Aries, and Taurus demand, with gross margin expanding 136 bps to 76.3%.
Revenue for the three months ended March 31, 2026, was $308.4 million, a 93% increase from $159.4 million in the same period last year. The growth was driven by higher overall unit shipments, particularly for Scorpio, Aries, and Taurus products, along with higher average selling prices from an increased mix of hardware modules and Scorpio products. Gross profit rose 97% to $235.1 million, with gross margin expanding 136 basis points to 76.3%, primarily due to favorable product mix. Operating income surged 448% to $61.8 million, reflecting strong operating leverage from revenue growth and margin expansion. Net income increased 152% to $80.3 million, supported by higher operating income and interest income.
The MD&A does not provide segment-level financial data; however, revenue growth was attributed to increased demand across the Scorpio, Aries, and Taurus product families, with a notable shift toward hardware modules and Scorpio products contributing to higher average selling prices and margin improvement.
Management did not provide specific forward guidance but stated that the company's cash, cash equivalents, and marketable securities of $1.2 billion are sufficient to fund operations for at least the next 12 months and beyond. The company expects to continue investing in research and development, sales and marketing, and capital expenditures to support growth. Future capital requirements depend on growth rate, market acceptance of products, and potential acquisitions.
As of March 31, 2026, Astera Labs holds a robust liquidity position with $148.3 million in cash and cash equivalents and $1,036.2 million in marketable securities, totaling $1,184.5 million. The company has no debt, and shareholders' equity stands at $1,493.9 million. Inventories increased slightly to $60.2 million from $59.0 million at year-end 2025, driven by higher work-in-progress ($46.6 million) partially offset by lower finished goods ($13.3 million). Goodwill surged to $87.7 million from $19.0 million due to the February 2026 acquisition of a data center acceleration solution provider for $74.0 million in total consideration (cash, holdback, and share-based consideration).
Total purchase commitments as of March 31, 2026 are $79.6 million, primarily related to third-party manufacturing subcontractors and software/cloud service agreements. The timing breakdown shows $29.6 million due in the remainder of 2026, $49.7 million in 2027-2028, and $0.4 million beyond 2028. Non-cancellable operating lease commitments total $52.7 million in future minimum payments, with a weighted-average remaining lease term of 6.5 years and a discount rate of 6.8%. Additionally, the company has $14.8 million in future obligations for a headquarters expansion in San Jose, California, with leases expected to commence between April 2026 and March 2027.
Astera Labs did not engage in share repurchases or pay dividends during the quarter. Capital expenditures were $7.6 million, primarily for production and laboratory equipment. The company invested $65.0 million in cash for a business combination. There is no debt outstanding. The company also issued a warrant to a customer in February 2026 for up to 3.3 million shares, with a grant-date fair value of $280.0 million, recognized as a reduction of revenue over time ($2.1 million in Q1 2026).
The company operates as a single operating segment. Revenue is heavily concentrated in Asia: Taiwan (30%), Singapore (30%), and China (29%) together accounted for 89% of total revenue in Q1 2026. The United States contributed 5%. Customer concentration is notable, with five customers each representing 10% or more of revenue: Customer A (29%), Customer B (21%), Customer C (16%), Customer D (12%), and Customer E (12%). Accounts receivable concentration similarly reflects a few large customers.